Express Scripts says controlling cancer-drug costs a tough new focus
April 29, 2015 at 09:57 AM EDT
April 29 (Reuters) - Pharmacy benefit manager Express Scripts Holding Co, which has aggressively negotiated lower costs of new hepatitis C drugs, on Wednesday said a new "focus area" will be subduing costs of a growing wave of pricey biotech cancer drugs.